Patient-derived organoids (PDOs) are miniature tumor models that are created by culturing postoperative or biopsy tumor tissues from patients in vitro in 3D. PDOs are highly effective in maintaining tumor tissue heterogeneity, degree of tumor cell differentiation, morphological characteristics, and molecular properties. They are an important tool for dynamic clinical studies of cancer and new drug development.